TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ACAD

ACADIA Pharmaceuticals Inc

Healthcare · Biotechnology

25.40$ -3.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ACAD
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.68 -1.21 -1.82 -1.78 -1.32 -1.03 -0.87 -0.78 -0.71 0.10 0.95 0.64
0.00 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.03 0.10 0.07
0.16 0.40 0.48 0.62 0.64 0.56 0.54 0.40 0.42 0.41 0.40 0.30
0.16 0.40 0.47 0.61 0.66 0.55 0.83 0.38 0.38 – – –
0.10 0.04 0.04 -0.05 -0.06 0.03 0.07 -0.15 0.23 0.11 0.02 -0.52
0.00 0.02 0.08 0.01 0.02 0.01 0.05 0.01 0.00 0.24 0.00 0.03
-0.90 1.47 -2.26 0.75 -0.56 -1.13 1.22 -0.44 0.45 0.20 -0.18 -1.77
0.00 0.00 0.00 0.00 – – – – – – – –
2.10 0.14 4.48 0.25 2.42 2.53 0.51 0.11 – – – –
2.10 0.14 4.61 0.25 2.42 2.53 0.51 0.11 0.05 0.15 0.04 0.29
0.52 0.40 0.53 -0.77 0.53 0.37 0.87 -1.11 -0.20 0.45 0.81 -0.83
-0.68 -1.23 -1.90 -1.78 -1.34 -1.03 -0.91 -0.79 -0.71 -0.14 0.94 0.61

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?